Ocular Therapeutics (3^rd Ed.)

The third edition of Ocular Therapeutics brings practitioners up to date with the latest advances in ophthalmic drugs. Divided into three sections, the book begins with discussion on the physiology of the eye, drug administration and the fundamental role of ocular therapeutics.

The second section examines the application of ocular therapeutics in ophthalmic surgery for many different disorders and the final section discusses recent advances and future developments.

This new edition has been fully updated with the addition of new drugs and delivery systems, covering all groups of drugs used worldwide in different clinical conditions of the eye.

Written by recognised international experts, many from the USA, the book is presented in an easy to read format and includes nearly 430 well-illustrated colour figures, tables, flow diagrams and chemical formulas.

Key points

• New edition bringing ophthalmologists up to date with latest advances in ophthalmic drugs
• Includes new drugs and delivery systems for all groups of drugs used worldwide
• Written by recognised international experts
• Nearly 430 figures, tables, flow diagrams and chemical formulas
• Previous edition published in 2006

Section 1: Fundamentals and Preliminary Considerations in Ocular Therapeutics

• Ocular Defense System
• Tear Film Physiology
• Aqueous Humor Dynamics
• Routes of Administration and Drug DeliverySystems in Ophthalmology
• Microorganisms and Ocular Diseases
• Unique Ocular Drug Delivery Systems
• Antibacterial Therapy
• Anti-inflammatory Therapy
• Antiviral Therapy
• Antifungal Therapy
• Antiglaucoma Therapy
• Antiallergy Therapy
• Local Anesthetic Agents
• Ophthalmic Viscosurgical Devices and Other Ocular Surgical Adjuncts
• Mydriatics and Cycloplegics
• Ophthalmic Dyes
• Ocular Lubricants and Artificial Tear Solutions
• Topical Immune Therapy
• Topical Hyperosmotic Agents
• Antiretroviral Drug Therapy of Ocular Infections in AIDS
• Sterilization, Disinfection and Antiseptics in Ophthalmology
• Miscellaneous Drugs in Ophthalmology
• Ocular Drug Toxicity: Complications
• Topical and Systemic Ophthalmic Drugs with Common Dosages
• Ocular Manifestations of Systemic Diseases
• Quick Look Tabulated Ocular Therapeutics Information

Section 2: Applied Ocular Therapeutics in Ophthalmic Surgery

• Comprehensive Review of Topical Ophthalmic Antibacterial Agents: Their Mechanisms of Action and Adverse Effects Including Long-Standing Drugs and the Most Recent Preparations
• Preoperative and Postoperative Antibiotic Prophylaxis in Cataract Surgery
• Management of Iatrogenic Inflammation of the Eye
• Management of Postrefractive Keratitis
• Ocular Pharmacotherapeutics in Corneal Refractive Surgery
• Antioxidants and Their Role in Ophthalmology
• Tetracyclins for Ocular Surface Diseases
• Clinical Applications of Antimycotic Agents in the Eye
• Recommended Antibiotic Dosages for Various Clinical Conditions of the Eye
• Endophthalmitis Prevention Strategies
• Management of Myopic Choroidal Neovascularization
• Treatment of Central Serous Choroidopathy
• Treatment of Retinal Angiomatous Proliferation
• Conjunctival Allergen Challenge for Evaluating Anti-inflammatory Therapy
• Steroid Therapy for Allergic Ocular Disease
• Optimizing Visual Outcomes with NSAIDs Therapy in Cataract and Refractive Surgeries
• Immunosuppressive Drugs in Ophthalmology
• Management of Cystoid Macular Edema  
• Blepharitis
• Trypan Blue in the Management of Mature Cataract
• Trypan Blue Assisted Epiretinal Membrane Removal
• Perfluorocarbon Liquids in Vitreoretinal Surgery
• Use of Tissue Adhesives in Ophthalmology
• Photodynamic Therapy (Verteporfin) in Age-related Macular Degeneration
• Indocyanine Green Angiography
• Management of Dry Eye—Current Trends and Recent Advances
• Management of Endophthalmitis: Antibiotic Schedule and Dosages
• Surgical Techniques of Glued IOL
• Intraocular Gases
• Pharmacology of Anti-VEGF Therapy

Section 3: Recent Advances in Ocular Therapeutics

• Toxic Anterior Segment Syndrome
• Anesthesia Trends in Ophthalmology
• Azithromycin in Ophthalmology: A New Therapy
• Use of Beta-adrenergic Blockers in Ocular Vascular Diseases
• Clinical Applications of Anti-inflammatory and Anti-protease Effects of Tetracyclines in Ocular Surface Disease
• Optimized NSAIDs and Antibacterial Regimen is Key to Ocular Surgical Prophylaxis  
• Ophthalmic Medications in Pediatric Age Group
• Management of Uveitis in Children
• Management of Anticoagulation Therapy in Elective Ophthalmic Procedures
• Ocular Pharmacology of Intravitreal Dexamethasone Sustained Release Implant
• Nanotechnology in Ophthalmology
• Photochemical Therapy for Corneal Infections
• Recent and Future Drugs in Ophthalmology

Ashok Garg MS PhD FIAO(Bel) FRCS FRSM ADM FAIMS FICA
Chairman and Medical Director, Garg Eye Institute and Research Center, Hisar, Haryana, India